Welcome to our dedicated page for KERN news (Ticker: KERN), a resource for investors and traders seeking the latest updates and insights on KERN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KERN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KERN's position in the market.
Akerna (Nasdaq: KERN) reports a significant increase in cannabis sales, surging 68% year-over-year from April 2019 to April 2020. First-time cannabis buyers among baby boomers aged 55+ tend to spend more on edibles, with 22% of their purchases compared to just 9% for younger consumers (18-34). Despite an 18% decrease in infused edibles sales, concentrates increased by 22%. The company's MJ Platform now offers Platform Insights, providing crucial analytics to operators, investors, and regulators, helping them make informed business decisions.
Akerna (Nasdaq: KERN) reports a recent decline in online cannabis orders and pickup methods as states reopen. After a surge in delivery orders due to COVID-19, in-person transactions are resurging. Daily deliveries peaked in April, now down by 50% in May compared to April's highs but still five times higher than January levels. Year-over-year sales from May 2019 to May 2020 grew by 157% with an average ticket size of $77.73. Notably, April 2020 sales rose by 68% compared to April 2019, with concentrates and cartridges showing growth, while infused edibles saw an 18% decrease.
Akerna (Nasdaq: KERN) reports significant increases in cannabis sales trends following the easing of curbside pickup restrictions in Nevada. As of May 7, pickup sales rose to 67% of total sales, with daily orders up 2,746% since the curbside option was introduced on May 1. Total daily sales grew 20% compared to April. Year-over-year comparisons show a 68% increase in total cannabis sales from April 2019 to April 2020, with average ticket sizes rising. Notably, concentrates and cartridges saw increases, while infused edibles declined.
Akerna (Nasdaq: KERN) announces the launch of a new feature that integrates with Metrc API, enabling single data entry for facility license transfers. This innovation is available via Trellis and MJ Platform, enhancing operational efficiency for clients in Metrc states. The integration aims to solve the issue of duplicated information entry, streamlining management processes. Clients will receive notifications about the product enhancements throughout May. Akerna, focused on regulatory compliance technology in the cannabis industry, has tracked over $18 billion in sales since its 2010 inception.
Summary not available.